EPs® 7630: Clinical Trials

1 trial of EPs® 7630, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 31Completed 1

Follow EPs® 7630: new trials by email Literature Review of EPs® 7630 trials Research Report on EPs® 7630

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hand, Foot, and Mouth Disease: Could EPs®7630 be a Treatment Option
EPs® 7630 - Hand, Foot, and Mouth Disease
Phase 2 / Phase 3CompletedEskisehir Osmangazi University2402019-06-012024-04-09

Conditions studied

Hand, Foot and Mouth Disease (1)

Sponsors

Eskisehir Osmangazi University (1)

Countries

Turkey (Türkiye) (1)

Results publications

PMID 38832001